Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19

NCT05398705 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Asymptomatic COVID-19

Interventions

DRUG: Cepharanthine
DRUG: Placebo
DRUG: Cepharanthine

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]